TABLE 5.
Detection of specific microorganisms in saliva of individuals prior to and in the days following dosing with Streptococcus salivarius K12a
Organism(s) | No. of subjects in which the indicated class of microbe was detected/total no. of subjects at the following sampling time:
|
Maximum CFU/ml detected in any single sample | ||||
---|---|---|---|---|---|---|
Predosing | Day 3 | Day 7 | Day 14 | Day 28 | ||
S. salivarius K12-like BLISc profile | 2/14 | 13/14 | 12/14 | 9/14 | 4/14 | NAd |
S. salivarius K12-like BLIS profile >50% | 2/14 | 7/14 | 7/14 | 3/14 | 1/14 | NA |
S. mutansb | 9/14 | 11/14 | 9/14 | 11/14 | 9/13 | 6.3e5 |
S. mutans >1e4 CFU/ml | 4/14 | 4/14 | 4/14 | 5/14 | 4/14 | NA |
S. mutans >1e5 CFU/ml | 2/14 | 2/14 | 1/14 | 1/14 | 1/14 | NA |
Lactobacilli | 6/14 | 5/14 | 4/14 | 7/14 | 2/14 | 2.8e5 |
Candida | 1/14 | NDe | 1/14 | 1/14 | 1/14 | 4.4e4 |
Coliforms | 1/14 | 2/14 | 0/14 | 1/14 | 0/14 | 140 |
Pseudomonas | 11/14 | 8/14 | 10/14 | 9/14 | 5/14 | 100 |
Staphylococcus aureus | 3/14 | 4/14 | 1/14 | 2/14 | 2/14 | 1,000 |
Subjects included 4 males and 10 females; mean age, 19 years.
P values for time point differences for S. mutans counts were not significant (>0.5 by nonparametric analysis of variance).
BLIS, bacteriocin-like inhibitory substance.
NA, not applicable.
ND, not determined.